Tamas

Multiple New Analyses Reinforce the Role of BAVENCIO® (avelumab) First-Line Maintenance as a Standard of Care in Patients with Locally Advanced or Metastatic Urothelial Carcinoma

Retrieved on: 
Monday, January 22, 2024

Data include real-world studies that confirm median overall survival (OS) of approximately 30 months in patients without progression after first-line chemotherapy.

Key Points: 
  • Data include real-world studies that confirm median overall survival (OS) of approximately 30 months in patients without progression after first-line chemotherapy.
  • These and other analyses will be presented at the 2024 American Society of Clinical Oncology’s annual Genitourinary Cancers Symposium, January 25-27, in San Francisco.
  • “Avelumab in the first-line maintenance setting is a standard of care for patients with locally advanced or metastatic bladder cancer, with a well-established efficacy and safety profile and supported by years of real-world experience.
  • READY CUP Italy Real-World Study: The prospective, noninterventional compassionate use program (CUP) provided Italian patients with locally advanced or metastatic UC early access to BAVENCIO first-line maintenance before reimbursement.

Multiple New Analyses Reinforce the Role of BAVENCIO® (avelumab) First-Line Maintenance as a Standard of Care in Patients with Locally Advanced or Metastatic Urothelial Carcinoma

Retrieved on: 
Monday, January 22, 2024

Data include real-world studies that confirm median overall survival (OS) of approximately 30 months in patients without progression after first-line chemotherapy.

Key Points: 
  • Data include real-world studies that confirm median overall survival (OS) of approximately 30 months in patients without progression after first-line chemotherapy.
  • These and other analyses will be presented at the 2024 American Society of Clinical Oncology’s annual Genitourinary Cancers Symposium, January 25-27, in San Francisco.
  • “Avelumab in the first-line maintenance setting is a standard of care for patients with locally advanced or metastatic bladder cancer, with a well-established efficacy and safety profile and supported by years of real-world experience.
  • READY CUP Italy Real-World Study: The prospective, noninterventional compassionate use program (CUP) provided Italian patients with locally advanced or metastatic UC early access to BAVENCIO first-line maintenance before reimbursement.

Hidden Road Launches Synthetic Prime Brokerage Offering, Route28

Retrieved on: 
Wednesday, October 25, 2023

LONDON, Oct. 25, 2023 /PRNewswire/ -- Hidden Road, the global credit network for institutions, today announced the launch of Route28, its new Synthetic Prime Brokerage offering covering OTC Swaps across all major asset classes, including FX, Equities, Commodities, Digital Assets, Energy and Rates.

Key Points: 
  • Commenting on the launch, Michael Higgins, Global Head of Business Development at Hidden Road, said, "Route28 is a continuation of Hidden Road's strategy to provide more efficient credit intermediation services.
  • Bringing to market a Synthetic Prime Brokerage offering–especially one without any clearing or technology fees–was an obvious extension our clients were looking for."
  • "We are excited to be a launch partner of Route28 and to see the commitment that Hidden Road is making to retail brokers like us in accessing a range of markets with their synthetic prime brokerage product.
  • "Hidden Road is one of those crucial players, having led the way with their innovative prime brokerage offering for crypto spot and perps.

Eco Forum Global Guiyang 2023 Discusses How to Achieve Green Development and Strengthen Ecological Cooperation

Retrieved on: 
Monday, July 10, 2023

GUIYANG, China, July 10, 2023 /PRNewswire/ -- A news report by Huanqiu.com:

Key Points: 
  • GUIYANG, China, July 10, 2023 /PRNewswire/ -- A news report by Huanqiu.com:
    The Eco Forum Global Guiyang 2023 kicked off on July 8.
  • At the Forum, China's dedication to promoting ecological conservation and tackling climate change was highlighted.
  • Ms. Indira Ranamagary, Deputy Speaker of the House of Representatives of Nepal said that Eco Forum Global Guiyang and other platforms provide a good opportunity for her country to learn about Guizhou's successful experiences in infrastructure development, agricultural development and ecological conservation.
  • The ultimate goals are to advance the high-quality construction of the natural protected area system, strengthen the supply capacity of ecological products, and safeguard ecological security.

Eco Forum Global Guiyang 2023 Discusses How to Achieve Green Development and Strengthen Ecological Cooperation

Retrieved on: 
Monday, July 10, 2023

GUIYANG, China, July 10, 2023 /PRNewswire/ -- A news report by Huanqiu.com:

Key Points: 
  • GUIYANG, China, July 10, 2023 /PRNewswire/ -- A news report by Huanqiu.com:
    The Eco Forum Global Guiyang 2023 kicked off on July 8.
  • At the Forum, China's dedication to promoting ecological conservation and tackling climate change was highlighted.
  • Ms. Indira Ranamagary, Deputy Speaker of the House of Representatives of Nepal said that Eco Forum Global Guiyang and other platforms provide a good opportunity for her country to learn about Guizhou's successful experiences in infrastructure development, agricultural development and ecological conservation.
  • The ultimate goals are to advance the high-quality construction of the natural protected area system, strengthen the supply capacity of ecological products, and safeguard ecological security.

Chemotherapy Alters Immune Cell Landscape in Pancreatic Cancer

Retrieved on: 
Wednesday, March 1, 2023

NEW YORK, March 1, 2023 /PRNewswire/ -- Chemotherapy affects the ability of a patient's immune system to attack pancreatic tumors, a new study shows.

Key Points: 
  • NEW YORK, March 1, 2023 /PRNewswire/ -- Chemotherapy affects the ability of a patient's immune system to attack pancreatic tumors, a new study shows.
  • Led by researchers at NYU Langone Health and its Perlmutter Cancer Center, the work revolves around the immune system, which includes T cells designed to attack foreign organisms like viruses.
  • The body also recognizes tumors as abnormal, but cancer cells hijack checkpoints to turn off immune responses.
  • A prominent type of immunotherapy seeks to shut down checkpoints, thereby making cancer cells "visible" again to the immune system.

New Analyses Reinforce Survival Benefit of BAVENCIO First-Line Maintenance Treatment in Patients With Advanced Urothelial Carcinoma

Retrieved on: 
Monday, February 13, 2023

These analyses reinforce the proven survival benefits of BAVENCIO® (avelumab) in the first-line maintenance setting for patients with locally advanced or metastatic urothelial carcinoma (UC).

Key Points: 
  • These analyses reinforce the proven survival benefits of BAVENCIO® (avelumab) in the first-line maintenance setting for patients with locally advanced or metastatic urothelial carcinoma (UC).
  • The findings presented today reinforce that all patients eligible for platinum-based chemotherapy, either cisplatin or carboplatin, can benefit from avelumab maintenance therapy.
  • The analysis also confirmed that the overall survival of BAVENCIO first-line maintenance were similar regardless of whether patients received cisplatin- or carboplatin-based chemotherapy.
  • “BAVENCIO remains the only immunotherapy to show improved overall survival in advanced UC patients in the first-line maintenance setting in a Phase III trial.

New Analyses Reinforce Survival Benefit of BAVENCIO First-Line Maintenance Treatment in Patients With Advanced Urothelial Carcinoma

Retrieved on: 
Monday, February 13, 2023

These analyses reinforce the proven survival benefits of BAVENCIO® (avelumab) in the first-line maintenance setting for patients with locally advanced or metastatic urothelial carcinoma (UC).

Key Points: 
  • These analyses reinforce the proven survival benefits of BAVENCIO® (avelumab) in the first-line maintenance setting for patients with locally advanced or metastatic urothelial carcinoma (UC).
  • The findings presented today reinforce that all patients eligible for platinum-based chemotherapy, either cisplatin or carboplatin, can benefit from avelumab maintenance therapy.
  • The analysis also confirmed that the overall survival of BAVENCIO first-line maintenance were similar regardless of whether patients received cisplatin- or carboplatin-based chemotherapy.
  • “BAVENCIO remains the only immunotherapy to show improved overall survival in advanced UC patients in the first-line maintenance setting in a Phase III trial.

Dremio Hosts Its Annual Subsurface LIVE Conference With Virtual and In-Person Offerings

Retrieved on: 
Wednesday, February 8, 2023

Dremio, the easy and open data lakehouse, announced it will host its annual Subsurface LIVE conference on March 1 – 2, 2023.

Key Points: 
  • Dremio, the easy and open data lakehouse, announced it will host its annual Subsurface LIVE conference on March 1 – 2, 2023.
  • The highly anticipated Subsurface LIVE 2023 will bring together esteemed data architects and distinguished data engineers to explore the latest open source innovations, drive best practices, and share real-world use cases!
  • Confirmed speakers for this can’t-miss industry conference include astronomer Julien Le Dem, Shopify’s Marc Leforet, Tabular’s Ryan Blue and Morgan Stanley’s Supreet Kaur.
  • Founded in 2020, this is the first year the conference will offer an in-person attendee experience.

Crisp® acquires Integral Group to expand supply chain visibility with EDI data and retail integrations

Retrieved on: 
Tuesday, January 31, 2023

Crisp , the leading open-data platform for the retail industry, has announced its acquisition of Electronic Data Interchange (EDI) platform Integral Group .

Key Points: 
  • Crisp , the leading open-data platform for the retail industry, has announced its acquisition of Electronic Data Interchange (EDI) platform Integral Group .
  • Integral Group currently serves hundreds of customers including manufacturers, distributors and 3PL providers, helping them achieve trade compliance across grocery, retail, pharmacy and automotive chains.
  • Hundreds of brands count on the Crisp platform for timely retail data, granular performance reports and actionable insights.
  • Welcoming Integral is an important step towards Crisp’s vision of realizing a more connected, high-performing, sustainable supply chain.